Exploring and investigating the long-term ramifications of fertility preservation in men with a history of cancer: a 10-year retrospective follow-up study

Authors

  • Kaavya Sathyamurthy Institution of Reproductive Medicine and Women’s Health Madras Medical Mission Hospital, Chennai, India
  • Kundavi K. M. Institution of Reproductive Medicine and Women’s Health Madras Medical Mission Hospital, Chennai, India
  • Geetha V. Institution of Reproductive Medicine and Women’s Health Madras Medical Mission Hospital, Chennai, India
  • Rashmi Institution of Reproductive Medicine and Women’s Health Madras Medical Mission Hospital, Chennai, India
  • Geovin R. Institution of Reproductive Medicine and Women’s Health Madras Medical Mission Hospital, Chennai, India
  • Yamini Institution of Reproductive Medicine and Women’s Health Madras Medical Mission Hospital, Chennai, India
  • Hema Nivedha Institution of Reproductive Medicine and Women’s Health Madras Medical Mission Hospital, Chennai, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20253881

Keywords:

Sperm cryopreservation, Fertility preservation, Cancer, Chemotherapy, Radiotherapy, Spontaneous fertility recovery

Abstract

Background: Cancer treatments such as chemotherapy, radiotherapy, and surgery can adversely affect male fertility, leading to temporary or permanent sterility. Sperm cryopreservation is the standard fertility preservation strategy for young male cancer patients prior to gonadotoxic therapy. However, utilization rates of stored samples remain low despite increased awareness and accessibility.

Methods: This retrospective study analyzed data from 136 male cancer patients who underwent sperm cryopreservation at Madras Medical Mission Hospital, Chennai, over a 10-year period. Patient records were reviewed to assess return rates for assisted reproduction, post-treatment semen analysis outcomes, and psychosocial factors influencing fertility-related decisions.

Results: None of the patients who banked sperm returned for assisted reproductive procedures. Post-treatment semen analysis was available for a subset of patients, among whom 82.9% demonstrated spontaneous recovery of fertility. Psychosocial barriers, including lack of a partner, financial constraints, and diminished reproductive intent, contributed to the non-utilization of cryopreserved sperm.

Conclusion: Although sperm cryopreservation offers an effective safeguard against treatment-induced infertility, its utilization remains minimal. The high rate of spontaneous fertility recovery and psychosocial limitations appear to influence decision-making. These findings highlight the need for individualized fertility counselling, systematic follow-up, and strategies to mitigate financial barriers. Integration of fertility preservation into comprehensive cancer survivorship programs is crucial to optimize reproductive outcomes and improve long-term quality of life in male cancer survivors.

Metrics

Metrics Loading ...

References

Yumura Y, Takeshima T, Komeya M, Karibe J, Kuroda S, Saito T. Long-Term Fertility Function Sequelae in Young Male Cancer Survivors. World J Mens Health. 2023;41(2):255-71. DOI: https://doi.org/10.5534/wjmh.220102

Pening D, Constant M, Bruynbroeck M, Delbaere A, Demeestere I. Impact of cancer on cryopreserved sperm quality and fertility: A cohort study. Health Sci Rep. 2022;5(4):726. DOI: https://doi.org/10.1002/hsr2.726

Tian En L, Brougham MFH, Wallace WHB, Mitchell RT. Impacts of platinum-based chemotherapy on subsequent testicular function and fertility in boys with cancer. Hum Reprod Update. 2020;26(6):874-85. DOI: https://doi.org/10.1093/humupd/dmaa041

Meistrich ML, Shetty G. Effects of chemotherapy and radiotherapy on spermatogenesis in adult males. Fertility and Sterility. 2008;89(2):1-11.

Su HI, Lacchetti C, Letourneau J, Partridge AH, Qamar R, Quinn GP. Fertility preservation in people with cancer: ASCO guideline update. J Clin Oncol. 2025;43(12):1488-515. DOI: https://doi.org/10.1200/JCO-24-02782

Meseguer M, Molina N, García-Velasco JA, Remohí J, Pellicer A, Garrido N. Sperm cryopreservation in oncological patients: a 14-year follow-up study. Fertil Steril. 2006;85(3):640-5. DOI: https://doi.org/10.1016/j.fertnstert.2005.08.022

Ferrari S, Paffoni A, Reschini M, Noli S, Dallagiovanna C, Guarneri C, Filippi F, Somigliana E. Variables affecting long-term usage rate of sperm samples cryopreserved for fertility preservation in cancer patients. Andrology. 2021;9(1):204-11. DOI: https://doi.org/10.1111/andr.12894

Liu X, Liu B, Liu S, Xian Y, Zhao W. Male cancer patient sperm cryopreservation for fertility preservation: 10-year monocentric experience. Basic Clin Androl. 2021;31(1):24. DOI: https://doi.org/10.1186/s12610-021-00140-w

Okada K, Fujisawa M. Recovery of Spermatogenesis Following Cancer Treatment with Cytotoxic Chemotherapy and Radiotherapy. World J Mens Health. 2019;37(2):166-74. DOI: https://doi.org/10.5534/wjmh.180043

Menzel V, Richter E, Helke C, Bürk BT, Erb HHH, Leike S, et al. Utilization of sperm cryopreservation in patients with testicular cancer. J Cancer Res Clin Oncol. 2024;150(4):201. DOI: https://doi.org/10.1007/s00432-024-05725-2

Harel S, Fermé C, Poirot C. Management of fertility in patients treated for Hodgkin’s lymphoma. Haematologica. 2011;96(11):1692-9. DOI: https://doi.org/10.3324/haematol.2011.045856

Cheson BD. Is BEACOPP better than ABVD. Curr Hematol Malig Rep. 2007;2(3):161-6. DOI: https://doi.org/10.1007/s11899-007-0022-2

Tamburrino L, Traini G, Marcellini A, Vignozzi L, Baldi E, Marchiani S. Cryopreservation of Human Spermatozoa: Functional, Molecular and Clinical Aspects. Int J Mol Sci. 2023;24:4656. DOI: https://doi.org/10.3390/ijms24054656

Wang Y, Jin L, Zong C, Zhang X. Effects of cisplatin, paclitaxel combined with high-dose methotrexate as adjuvant therapy on survival rates in osteosarcoma patients, and analysis of influencing factors. Am J Cancer Res. 2025;15(6):2618-30. DOI: https://doi.org/10.62347/RLWT8295

Agarwal A, Ong C, Durairajanayagam D. Contemporary and future insights into fertility preservation in male cancer patients. Transl Androl Urol. 2014;3(1):27-40.

Soltani S, Aghaee A, Rasoul Zakavi S, Mottaghi M, Emadzadeh M, Kasaeian Naeini S. Effects of radioiodine therapy on fertility indicators among men with differentiated thyroid cancer: A cohort study. Int J Reprod Biomed. 2023;21(5):387-94. DOI: https://doi.org/10.18502/ijrm.v21i5.13472

Williams DH. Sperm banking and the cancer patient. Ther Adv Urol. 2010;2(1):19-34. DOI: https://doi.org/10.1177/1756287210368279

Vassena D, Rita C. Barriers and factors associated with significant delays to initial consultation and treatment for infertile patients and partners of infertile patients. Reproductive BioMed. 2021;2:43. DOI: https://doi.org/10.1016/j.rbmo.2021.09.002

Lehmann V, Keim MC, Nahata L, Shultz EL, Klosky JL, Tuinman MA. Fertility-related knowledge and reproductive goals in childhood cancer survivors. Human Reproduction. 2017;32(11):2250-3. DOI: https://doi.org/10.1093/humrep/dex297

Giona S. The epidemiology of testicular cancer. Exon Publications. 2022;5:107-16. DOI: https://doi.org/10.36255/exon-publications-urologic-cancers-epidemiology-testicular-cancer

Stawińska-Witoszyńska B, Wojtyła-Buciora P, Więckowska B, Krzywinska-Wiewiorowska M, Gromadecka-Sutkiewicz M. Malignant testicular tumour incidence and mortality trends. Contemp Oncol (Pozn). 2016;20(1):58-62. DOI: https://doi.org/10.5114/wo.2016.58501

Shankara-Narayana N, Di Pierro I, Fennell C, Ly LP, Bacha F, Vrga L, et al. Sperm cryopreservation prior to gonadotoxic treatment: experience of a single academic centre over 4 decades. Human Reprod. 2019;34(5):795-803. DOI: https://doi.org/10.1093/humrep/dez026

Tang W, Deng C, Gao J, Tian S, Wei N, Li B, et al. An evaluation of the population characteristics, semen quality, and utilization status of autologous sperm cryopreservation and fertility preservation in for 662 patients: a 6-year monocentric retrospective study. Basic Clin Androl. 2022;32(1):18. DOI: https://doi.org/10.1186/s12610-022-00169-5

Ku JY, Park NC, Jeon TG, Park HJ. Semen Analysis in Cancer Patients Referred for Sperm Cryopreservation before Chemotherapy over a 15-Year Period in Korea. World J Mens Health. 2015;33(1):8-13. DOI: https://doi.org/10.5534/wjmh.2015.33.1.8

Massarotti C, Scaruffi P, Lambertini M, Sozzi F, Remorgida V, Anserini P. Beyond fertility preservation: role of the oncofertility unit in the reproductive and gynecological follow-up of young cancer patients. Human Reproduction. 2019;34(8):1462-9. DOI: https://doi.org/10.1093/humrep/dez108

Fernandez P, Alvarez M. Spontaneous recovery of fertility in male cancer survivors. Int J Androl. 2019;42(3):215-23.

Quinn GP, Bayefsky M, Cherven B, Ghazal LV, Goldman KN. Update and new advances in fertility preservation and cancer. CA Cancer J Clin. 2025;75(6):602-29. DOI: https://doi.org/10.3322/caac.70029

Downloads

Published

2025-11-27

How to Cite

Sathyamurthy, K., K. M., K., V., G., Rashmi, R., G., Yamini, & Nivedha, H. (2025). Exploring and investigating the long-term ramifications of fertility preservation in men with a history of cancer: a 10-year retrospective follow-up study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 14(12), 4181–4186. https://doi.org/10.18203/2320-1770.ijrcog20253881

Issue

Section

Original Research Articles